Related Experiment Video

Updated: Jun 1, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

Tbx1, subpulmonary myocardium and conotruncal congenital heart defects

Pauline Parisot1, Karim Mesbah, Magali Théveniau-Ruissy

  • 1Developmental Biology Institute of Marseilles-Luminy, UMR 6216/CNRS, Université de la Méditerranée, Marseilles, France.

Birth Defects Research. Part A, Clinical and Molecular Teratology
|May 19, 2011
PubMed

Insights

Conotruncal heart defects arise from issues in outflow tract development. Tbx1 gene regulation of the second heart field is crucial for preventing these congenital anomalies.

Area of Science:

  • Developmental Biology
  • Congenital Heart Disease
  • Genetics

Background:

  • Conotruncal congenital heart defects (CCHDs) represent a significant portion of all congenital heart defects, stemming from improper septation and alignment of ventricular outlets.
  • These defects lead to incomplete separation of pulmonary and systemic circulation at birth, impacting fetal cardiac development.
  • The embryonic outflow tract (OFT) is vital for normal development, originating from the second heart field progenitor cells.

Purpose of the Study:

  • To review the critical role of Tbx1 in regulating the second heart field (SHF) during embryonic development.
  • To investigate the specific contribution of Tbx1 to the development of myocardial cells at the base of the pulmonary trunk.
  • To provide mechanistic insights into CCHDs, particularly those associated with DiGeorge syndrome.

Main Methods:

  • Review of existing literature on Tbx1 function, SHF development, and conotruncal anomaly pathogenesis.
  • Analysis of genetic and developmental data related to Tbx1 and its downstream targets.
  • Discussion of signaling pathways including retinoic acid, hedgehog, and semaphorin in OFT development.

Main Results:

  • Tbx1 is a key transcriptional regulator essential for SHF progenitor cell deployment.
  • Haploinsufficiency of Tbx1 in DiGeorge syndrome patients leads to a spectrum of CCHDs.
  • The subpulmonary myocardium is identified as a clinically relevant component of the SHF.

Conclusions:

  • Tbx1 plays a critical role in the development of the subpulmonary myocardium, a key component of the SHF.
  • Dysregulation of Tbx1 and associated signaling pathways contributes to the etiology of common CCHDs.
  • Understanding these developmental mechanisms offers new insights for potential therapeutic strategies for congenital heart defects.

More Related Videos

A Pipeline to Characterize Structural Heart Defects in the Fetal Mouse08:19

A Pipeline to Characterize Structural Heart Defects in the Fetal Mouse

Published on: December 16, 2022

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry13:13

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry

Published on: September 23, 2014

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...